15 citations
,
December 2020 in “Pharmacology Research & Perspectives” Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.
30 citations
,
February 2021 in “Journal of Medical Virology” This review explored the role of the Transmembrane Serine Protease 2 (TMPRSS2) in influencing the susceptibility and pathogenicity of SARS-CoV-2 across different population groups. It highlighted that the cleavage of the viral spike protein by TMPRSS2 is crucial for viral entry into host cells, and variations in the expression of the TMPRSS2 gene among ethnic groups could impact COVID-19 infection rates and outcomes. The review also discussed potential treatments involving TMPRSS2 protease blockers and inhibitors as promising strategies for managing COVID-19.
176 citations
,
May 2020 in “Dermatologic Therapy” COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.
82 citations
,
June 2020 in “Inflammation Research” Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.
14 citations
,
July 2021 in “Reviews in endocrine and metabolic disorders” SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.